Skip to main content

Featured

Market Cools as Nvidia’s Blowout Earnings Fail to Ignite Futures

  U.S. stock futures were mixed Thursday morning as investors digested Nvidia’s latest blockbuster earnings—results that impressed on paper but didn’t translate into broad market enthusiasm. Dow futures edged slightly higher, while S&P 500 and Nasdaq futures hovered near the flatline, reflecting a cautious mood across Wall Street. Nvidia delivered strong beats on quarterly revenue and profit, along with guidance that topped expectations. Despite the stellar numbers, the stock’s initial surge faded as traders questioned whether the AI boom can continue delivering outsized returns. Shares ultimately pared gains to under 1% in early trading. The broader market’s hesitation stems from growing concerns about the sustainability of heavy AI investment. Salesforce’s weaker outlook added to the uncertainty, dragging software shares and reinforcing fears that not all tech giants will benefit equally from the AI wave. Meanwhile, geopolitical tensions—including renewed U.S.–Iran nuclea...
Post a Comment
Read more

article

Labels

Pharmacare in Canada: A Dream or a Reality?

 


The fate of Canada's pharmacare plan is uncertain as the federal government faces challenges in implementing a universal drug coverage program, even if a bill to create one passes in Parliament. Bill C-213, the Canada Pharmacare Act, aims to establish a national framework for pharmacare that would ensure all Canadians have access to prescription drugs based on their medical needs, not their ability to pay. 

However, the bill does not specify how the program would be funded, administered or negotiated with the provinces and territories, leaving many questions unanswered about the feasibility and cost-effectiveness of pharmacare. Some experts and stakeholders have expressed doubts about whether Ottawa has the political will, the constitutional authority and the fiscal capacity to deliver on its promise of pharmacare, especially in the wake of the COVID-19 pandemic that has strained the health care system and the public purse.

Labels:

Comments

Post a Comment